Related Experiment Video
Updated: May 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[National Survey on Procedure Dose of Endovascular Treatment for Lower Extremity Artery Disease]
Tomomichi Ishibashi1, Yoshinori Takao2, Toru Ishibashi3
1Department of Radiological Technology, Tsukuba Medical Center Hospital.
Purpose:
The objective of this study is to elucidate the current status of procedural radiation doses for endovascular treatment (EVT) of lower extremity artery disease (LEAD) in Japan and to validate the diagnostic reference level (DRL) quantity.
Methods:
Survey requests were mailed to 493 facilities across Japan. The study targeted cases of EVT for LEAD performed between April 1, 2020, and March 31, 2022, with a maximum of 10 cases collected per facility. We investigated the displayed values of cumulative air kerma at the patient entrance reference point (Ka.r), the air kerma-area product (PKA) and the fluoroscopy time (FT) for all EVT procedures for LEAD (All EVT) and by treatment site.
Results:
Data were collected from 1638 cases across 167 facilities. The median values for All EVT were Ka.r: 150 mGy, PKA: 30 Gy·cm2, and FT: 28.6 min. The highest Ka.r and PKA were observed in the aortoiliac (AI) region (286 mGy, 59 Gy·cm2), while the lowest were in the below-the-knee (BTK) region (81 mGy, 15 Gy·cm2) (p<0.001). The shortest FT was recorded in the AI region with a median of 23.8 min and the longest in the BTK region at 32.2 min (p<0.001). Significant differences in Ka.r, PKA, and FT were observed across the treatment sites for EVT for LEAD (p<0.001).
Conclusion:
In EVT for LEAD, it is necessary to set the DRL quantity according to the anatomical site being treated, using the dose values indicated by the angiographic equipment, such as Ka.r and PKA.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies